Delivery Order SPE2DB22D9353-SPE2DB25FX2CJ
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,268.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. The contract is for the delivery of 0.5ML VISIONBLUE 0.06% syringes and has a completion date of May 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,632.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on July 23, 2025, represents one of numerous task orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026....
- The Defense Logistics Agency issued a delivery order valued at $5,170.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, is issued under the company's larger Indefinite Delivery Contract with DLA valued at $499.99 million and valid through November 2026. The delivery order employs firm fixed-price pricing and carries no...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,638.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on August 19, 2025, with an ultimate completion date of August 22, 2025, was executed without a set-aside designation. DMS Pharmaceutical Group Inc. will deliver pharmaceutical products to support federal medical supply needs, with the place of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,638.72 on August 19, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, is issued under the company's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- The Defense Logistics Agency issued a delivery order valued at $1,526.37 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order falls under the SPE2DB Indefinite Delivery Contract (IDC), a $500 million single-award vehicle through which DLA procures pharmaceutical products and medical supplies for Department of Defense...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order valued at $46,257.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $70,817.80 by the Defense Logistics Agency's Medical Supply Chain division on August 11, 2025. This delivery order, with an ultimate completion date of August 18, 2025, is issued under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026. The award carries no set-aside...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2CJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader federal marketplace. The contractor will perform the delivery at its Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, under the SPE2DB program. The IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to provide branded and generic prescription drugs, biologics, medical consumables, and specialized pharmaceutical products directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/19/25 |